Pub Date : 2024-12-01Epub Date: 2024-11-20DOI: 10.1080/17501911.2024.2430166
Tao Wu, Li Zeng, Chao Peng, Zheng Zhao, Weihao Mu, Song Wang, Deli Tan
Aims: To investigate mechanism of lncRNA SNHG12 induced macrophage-myofibroblast transition (MMT) in cancer-associated fibroblasts (CAFs)-derived extracellular vesicles (EVs) in non-small cell lung cancer (NSCLC).
Method: CAFs EVs were isolated from human NSCLC tissue and adjacent cancerous tissue (n = 3), and their morphology and particle size were evaluated. Macrophages and MMT cells with different phenotypes were detected, and the binding relationship of lncRNA SNHG12, miR-181a-5p, and Smad3 was verified.
Result: LncRNA SNHG12 derived from CAFs-EVs promoted the transformation of M2 macrophages into MMT. In addition, lncRNA-SNHG12 increased the expression of Smad3 which was significantly upregulated in MMT through sponge of miR-181a-5p.
Conclusion: LncRNA SNHG12 derived from CAFs-EV induced MMT in NSCLC.
{"title":"SNHG12 in cancer-associated fibroblast-derived extracellular vesicle induces macrophage-myofibroblast transition.","authors":"Tao Wu, Li Zeng, Chao Peng, Zheng Zhao, Weihao Mu, Song Wang, Deli Tan","doi":"10.1080/17501911.2024.2430166","DOIUrl":"10.1080/17501911.2024.2430166","url":null,"abstract":"<p><strong>Aims: </strong>To investigate mechanism of lncRNA SNHG12 induced macrophage-myofibroblast transition (MMT) in cancer-associated fibroblasts (CAFs)-derived extracellular vesicles (EVs) in non-small cell lung cancer (NSCLC).</p><p><strong>Method: </strong>CAFs EVs were isolated from human NSCLC tissue and adjacent cancerous tissue (<i>n</i> = 3), and their morphology and particle size were evaluated. Macrophages and MMT cells with different phenotypes were detected, and the binding relationship of lncRNA SNHG12, miR-181a-5p, and Smad3 was verified.</p><p><strong>Result: </strong>LncRNA SNHG12 derived from CAFs-EVs promoted the transformation of M2 macrophages into MMT. In addition, lncRNA-SNHG12 increased the expression of Smad3 which was significantly upregulated in MMT through sponge of miR-181a-5p.</p><p><strong>Conclusion: </strong>LncRNA SNHG12 derived from CAFs-EV induced MMT in NSCLC.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1415-1427"},"PeriodicalIF":3.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-11-14DOI: 10.1080/17501911.2024.2426441
Anne K Bozack, Leonardo Trasande
Exposure to pollutants and chemicals during critical developmental periods in early life can impact health and disease risk across the life course. Research in environmental epigenetics has provided increasing evidence that prenatal exposures affect epigenetic markers, particularly DNA methylation. In this article, we discuss the role of DNA methylation in early life programming and review evidence linking the intrauterine environment to epigenetic modifications, with a focus on exposure to tobacco smoke, metals, and endocrine-disrupting chemicals. We also discuss challenges and novel approaches in environmental epigenetic research and explore the potential of epigenetic biomarkers in studies of pediatric populations as indicators of exposure and disease risk. Overall, we aim to highlight how advancements in environmental epigenetics may transform our understanding of early-life exposures and inform new approaches for supporting long-term health.
在生命早期的关键发育时期接触污染物和化学品会影响整个生命过程中的健康和疾病风险。环境表观遗传学的研究提供了越来越多的证据,证明产前暴露会影响表观遗传标记,尤其是 DNA 甲基化。在本文中,我们将讨论 DNA 甲基化在生命早期编程中的作用,并回顾将宫内环境与表观遗传修饰联系起来的证据,重点是烟草烟雾、金属和干扰内分泌的化学物质的暴露。我们还讨论了环境表观遗传研究中的挑战和新方法,并探讨了表观遗传生物标志物在儿科人群研究中作为暴露和疾病风险指标的潜力。总之,我们旨在强调环境表观遗传学的进步如何改变我们对生命早期暴露的理解,并为支持长期健康提供新方法。
{"title":"Prenatal chemical exposures and the methylome: current evidence and opportunities for environmental epigenetics.","authors":"Anne K Bozack, Leonardo Trasande","doi":"10.1080/17501911.2024.2426441","DOIUrl":"10.1080/17501911.2024.2426441","url":null,"abstract":"<p><p>Exposure to pollutants and chemicals during critical developmental periods in early life can impact health and disease risk across the life course. Research in environmental epigenetics has provided increasing evidence that prenatal exposures affect epigenetic markers, particularly DNA methylation. In this article, we discuss the role of DNA methylation in early life programming and review evidence linking the intrauterine environment to epigenetic modifications, with a focus on exposure to tobacco smoke, metals, and endocrine-disrupting chemicals. We also discuss challenges and novel approaches in environmental epigenetic research and explore the potential of epigenetic biomarkers in studies of pediatric populations as indicators of exposure and disease risk. Overall, we aim to highlight how advancements in environmental epigenetics may transform our understanding of early-life exposures and inform new approaches for supporting long-term health.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1443-1451"},"PeriodicalIF":3.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurofibromatosis (NF) is identified as genetic disorder characterized by multiple tumors on nerve tissues. NF1 is the most prevalent form, identified by neurofibromas and skin changes. NF1 is the most prevalent neurofibromatosis disorder, distinct from the rarer NF2 and schwannomatosis (SWN) conditions. NF2, including NF2-related SWN (NF2-SWN), predominantly involves schwannoma formation and differs from NF1 in its genetic basis and clinical presentation. Despite the established genetic basis of NF, effective treatments remain scarce. Long non-coding RNAs (lncRNAs) have emerged as important regulators of gene expression, impacting pathways vital to tumor biology. This review explores the lncRNAs role in NF pathogenesis along with their potential as therapeutic targets. LncRNAs such as ANRIL and H19 show dysregulated expression in NF, influencing signaling pathways like Ras/MAPK and JAK/STAT, thereby contributing to tumor development. Understanding these interactions sheds light on the molecular mechanisms underlying NF and highlights lncRNAs as potential biomarkers of diagnosis and prognosis of NF. Additionally, therapeutic strategies targeting lncRNAs with antisense oligonucleotides (ASOs) or CRISPR-Cas9 offer promising treatment options. The present review emphasizes crucial role of lncRNAs in NF pathogenesis and their promise to create innovative treatments, aiming to improve patient outcomes and meet the urgent need for effective NF therapies.
{"title":"Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.","authors":"Md Sadique Hussain, Somya Sharma, Alka Kumari, Almaz Kamran, Gurusha Bahl, Ajay Singh Bisht, Ayesha Sultana, Sumel Ashique, Prasanna Srinivasan Ramalingam, Sivakumar Arumugam","doi":"10.1080/17501911.2024.2430170","DOIUrl":"10.1080/17501911.2024.2430170","url":null,"abstract":"<p><p>Neurofibromatosis (NF) is identified as genetic disorder characterized by multiple tumors on nerve tissues. NF1 is the most prevalent form, identified by neurofibromas and skin changes. NF1 is the most prevalent neurofibromatosis disorder, distinct from the rarer NF2 and schwannomatosis (SWN) conditions. NF2, including NF2-related SWN (NF2-SWN), predominantly involves schwannoma formation and differs from <i>NF1</i> in its genetic basis and clinical presentation. Despite the established genetic basis of NF, effective treatments remain scarce. Long non-coding RNAs (lncRNAs) have emerged as important regulators of gene expression, impacting pathways vital to tumor biology. This review explores the lncRNAs role in NF pathogenesis along with their potential as therapeutic targets. LncRNAs such as <i>ANRIL</i> and <i>H19</i> show dysregulated expression in NF, influencing signaling pathways like Ras/MAPK and JAK/STAT, thereby contributing to tumor development. Understanding these interactions sheds light on the molecular mechanisms underlying NF and highlights lncRNAs as potential biomarkers of diagnosis and prognosis of NF. Additionally, therapeutic strategies targeting lncRNAs with antisense oligonucleotides (ASOs) or CRISPR-Cas9 offer promising treatment options. The present review emphasizes crucial role of lncRNAs in NF pathogenesis and their promise to create innovative treatments, aiming to improve patient outcomes and meet the urgent need for effective NF therapies.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1453-1464"},"PeriodicalIF":3.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142727424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-11-24DOI: 10.1080/17501911.2024.2430943
Abigail Gaylord, Elizabeth A Holzhausen, Bridget Chalifour, William B Patterson, Pei Wen Tung, Andrea A Baccarelli, Michael I Goran, Tanya L Alderete, Allison Kupsco
Aims: To describe tDRs in human milk EVs and their associations with maternal body mass index, age, dietary indices, breastfeeding frequency, season and time of milk collection in a Latina population.
Materials & methods: We sequenced small RNAs from EVs from 109 mature human milk samples collected at 1 month after delivery in the Southern California Mother's Milk Study. We grouped tDRs using hierarchical clustering and clusters were compared across tDR characteristics. We analyzed associations of tDRs with intrinsic maternal variables (body mass index, age), maternal nutrition (caloric intake, Healthy Eating Index, Dietary Inflammatory Index), and variables related to feeding and milk collection (breastfeeding frequency, season and time of milk collection) using negative binomial models.
Results: We identified 338 tDRs expressed in 90% or more of milk EV samples, of which 113 were identified in all samples. tDR-1:26-Gly-CCC-1-M4 accounted for most reads (79%). Pathway analysis revealed a wide array of biological processes and disease mechanisms across the four tDR clusters. tDRs were associated with season of collection, time of collection, breastfeeding frequency, and the dietary inflammatory index.
Conclusions: tDRs are abundant in milk EVs and may be sensitive to maternal diet, seasonality, time of day, and breastfeeding frequency.
{"title":"tRNA-derived RNAs in human milk extracellular vesicles and associations with breastfeeding variables and maternal diet.","authors":"Abigail Gaylord, Elizabeth A Holzhausen, Bridget Chalifour, William B Patterson, Pei Wen Tung, Andrea A Baccarelli, Michael I Goran, Tanya L Alderete, Allison Kupsco","doi":"10.1080/17501911.2024.2430943","DOIUrl":"10.1080/17501911.2024.2430943","url":null,"abstract":"<p><strong>Aims: </strong>To describe tDRs in human milk EVs and their associations with maternal body mass index, age, dietary indices, breastfeeding frequency, season and time of milk collection in a Latina population.</p><p><strong>Materials & methods: </strong>We sequenced small RNAs from EVs from 109 mature human milk samples collected at 1 month after delivery in the Southern California Mother's Milk Study. We grouped tDRs using hierarchical clustering and clusters were compared across tDR characteristics. We analyzed associations of tDRs with intrinsic maternal variables (body mass index, age), maternal nutrition (caloric intake, Healthy Eating Index, Dietary Inflammatory Index), and variables related to feeding and milk collection (breastfeeding frequency, season and time of milk collection) using negative binomial models.</p><p><strong>Results: </strong>We identified 338 tDRs expressed in 90% or more of milk EV samples, of which 113 were identified in all samples. tDR-1:26-Gly-CCC-1-M4 accounted for most reads (79%). Pathway analysis revealed a wide array of biological processes and disease mechanisms across the four tDR clusters. tDRs were associated with season of collection, time of collection, breastfeeding frequency, and the dietary inflammatory index.</p><p><strong>Conclusions: </strong>tDRs are abundant in milk EVs and may be sensitive to maternal diet, seasonality, time of day, and breastfeeding frequency.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1429-1441"},"PeriodicalIF":3.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622811/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-11-25DOI: 10.1080/17501911.2024.2426450
Seung-Gi Jin, Jennifer Johnson, Zhijun Huang, Wei Cui, Thomas Dunwell, Gerd P Pfeifer
Aims: Mammalian genomes encode 12 proteins that contain a CXXC zinc finger domain. Most members of this family are large multi-domain proteins that function in the control of DNA methylation and histone methylation patterns. CXXC5 is a smaller member of the family, along with its closest homologue CXXC4. These two proteins lack known catalytic domains. Here, we have characterized CXXC5 in mouse embryonic stem (ES) cells.
Materials & methods: We used gene knockouts, RNA sequencing, and DNA methylation analysis by whole-genome bisulfite sequencing.
Results & conclusions: We show that CXXC5 is a nuclear protein that interacts with 5-methylcytosine oxidases (TET proteins). Removal of CXXC5 from ES cells leads to very few changes in gene expression. CXXC5 extensively colocalizes with TET1 and TET2 at CpG islands. CXXC5 inactivation leads to a substantial reduction of DNA methylation levels that affects all genomic compartments including genic and intergenic regions and CpG island shores. We propose a model in which CXXC5 serves as an anchor for TET proteins at CpG islands. In the absence of CXXC5, the 5-methylcytosine oxidases become dislodged from CpG islands and are enabled to induce genome-scale DNA demethylation. Thus, CXXC5 serves as a stabilizer of DNA methylation patterns.
目的:哺乳动物基因组编码了 12 个含有 CXXC 锌指结构域的蛋白质。该家族的大多数成员都是大型多结构域蛋白,具有控制 DNA 甲基化和组蛋白甲基化模式的功能。CXXC5 及其最接近的同源物 CXXC4 是该家族中较小的成员。这两个蛋白缺乏已知的催化结构域。在此,我们对小鼠胚胎干(ES)细胞中的 CXXC5 进行了鉴定:我们使用了基因敲除、RNA测序和全基因组亚硫酸氢盐测序进行DNA甲基化分析:我们发现,CXXC5是一种与5-甲基胞嘧啶氧化酶(TET蛋白)相互作用的核蛋白。从 ES 细胞中移除 CXXC5 只导致基因表达的极少变化。CXXC5 与 CpG 岛上的 TET1 和 TET2 广泛共定位。CXXC5 失活导致 DNA 甲基化水平大幅降低,影响到所有基因组区,包括基因区、基因间区和 CpG 岛岸。我们提出了一个模型,在该模型中,CXXC5 是 CpG 岛上 TET 蛋白的锚。如果缺乏 CXXC5,5-甲基胞嘧啶氧化酶就会脱离 CpG 岛,从而诱导基因组规模的 DNA 去甲基化。因此,CXXC5 是 DNA 甲基化模式的稳定剂。
{"title":"CXXC5 stabilizes DNA methylation patterns in mouse embryonic stem cells.","authors":"Seung-Gi Jin, Jennifer Johnson, Zhijun Huang, Wei Cui, Thomas Dunwell, Gerd P Pfeifer","doi":"10.1080/17501911.2024.2426450","DOIUrl":"10.1080/17501911.2024.2426450","url":null,"abstract":"<p><strong>Aims: </strong>Mammalian genomes encode 12 proteins that contain a CXXC zinc finger domain. Most members of this family are large multi-domain proteins that function in the control of DNA methylation and histone methylation patterns. CXXC5 is a smaller member of the family, along with its closest homologue CXXC4. These two proteins lack known catalytic domains. Here, we have characterized CXXC5 in mouse embryonic stem (ES) cells.</p><p><strong>Materials & methods: </strong>We used gene knockouts, RNA sequencing, and DNA methylation analysis by whole-genome bisulfite sequencing.</p><p><strong>Results & conclusions: </strong>We show that CXXC5 is a nuclear protein that interacts with 5-methylcytosine oxidases (TET proteins). Removal of CXXC5 from ES cells leads to very few changes in gene expression. CXXC5 extensively colocalizes with TET1 and TET2 at CpG islands. CXXC5 inactivation leads to a substantial reduction of DNA methylation levels that affects all genomic compartments including genic and intergenic regions and CpG island shores. We propose a model in which CXXC5 serves as an anchor for TET proteins at CpG islands. In the absence of CXXC5, the 5-methylcytosine oxidases become dislodged from CpG islands and are enabled to induce genome-scale DNA demethylation. Thus, CXXC5 serves as a stabilizer of DNA methylation patterns.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1351-1363"},"PeriodicalIF":3.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622772/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-11-08DOI: 10.1080/17501911.2024.2419362
Vanessa Nicolì, Marianna Giangreco, Eleonora Pardini, Iacopo Petrini, Diana Bacchin, Vittorio Aprile, Franca Melfi, Marco Lucchi, Melania Guida, Roberta Ricciardi, Michelangelo Maestri, Martina Lari, Lucia Migliore, Andrea Stoccoro, Fabio Coppedè
Aim: To investigate DNA methylation levels of a panel of genes in thymic epithelial tumors (TETs).Materials & methods: We selected 15 genes among the most promising epigenetic biomarkers of TETs and evaluated their methylation levels in 71 TET samples.Results: thymic carcinomas (TCs) showed hypermethylation of GHSR and ELF3 genes and reduced IL1RN methylation levels compared with thymomas (TMs) and healthy thymic tissues. RAG1 was hypomethylated in TMs compared with healthy thymic tissues. No difference in the methylation levels of the investigated genes was seen among TM stages and subtypes. No changes in blood methylation levels of the investigated genes were seen among TET subtypes.Conclusion: The present study confirms GHSR, ELF3, IL1RN and RAG1 as TET epigenetic biomarkers.
{"title":"DNA methylation analysis of multiple genes in thymic epithelial tumors.","authors":"Vanessa Nicolì, Marianna Giangreco, Eleonora Pardini, Iacopo Petrini, Diana Bacchin, Vittorio Aprile, Franca Melfi, Marco Lucchi, Melania Guida, Roberta Ricciardi, Michelangelo Maestri, Martina Lari, Lucia Migliore, Andrea Stoccoro, Fabio Coppedè","doi":"10.1080/17501911.2024.2419362","DOIUrl":"10.1080/17501911.2024.2419362","url":null,"abstract":"<p><p><b>Aim:</b> To investigate DNA methylation levels of a panel of genes in thymic epithelial tumors (TETs).<b>Materials & methods:</b> We selected 15 genes among the most promising epigenetic biomarkers of TETs and evaluated their methylation levels in 71 TET samples.<b>Results:</b> thymic carcinomas (TCs) showed hypermethylation of <i>GHSR</i> and <i>ELF3</i> genes and reduced <i>IL1RN</i> methylation levels compared with thymomas (TMs) and healthy thymic tissues. <i>RAG1</i> was hypomethylated in TMs compared with healthy thymic tissues. No difference in the methylation levels of the investigated genes was seen among TM stages and subtypes. No changes in blood methylation levels of the investigated genes were seen among TET subtypes.<b>Conclusion:</b> The present study confirms <i>GHSR, ELF3, IL1RN</i> and <i>RAG1</i> as TET epigenetic biomarkers.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1337-1350"},"PeriodicalIF":3.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142603177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-11-08DOI: 10.1080/17501911.2024.2419357
Cal Rosete, Annie Vogel Ciernia
Histone deacetylase 3 (HDAC3) is a critical regulator of gene expression, influencing a variety of cellular processes in the central nervous system. As such, dysfunction of this enzyme may serve as a key driver in the pathophysiology of various neuropsychiatric disorders and neurodegenerative diseases. HDAC3 plays a crucial role in regulating neuroinflammation, and is now widely recognized as a major contributor to neurological conditions, as well as in promoting neuroprotective recovery following brain injury, hemorrhage and stroke. Emerging evidence suggests that pharmacological inhibition of HDAC3 can mitigate behavioral and neuroimmune deficits in various brain diseases and disorders, offering a promising therapeutic strategy. Understanding HDAC3 in the healthy brain lays the necessary foundation to define and resolve its dysfunction in a disease state. This review explores the mechanisms of HDAC3 in various cell types and its involvement in disease pathology, emphasizing the potential of HDAC3 inhibition to address neuroimmune, gene expression and behavioral deficits in a range of neurodegenerative and neuropsychiatric conditions.
{"title":"The Two Faces of HDAC3: Neuroinflammation in Disease and Neuroprotection in Recovery.","authors":"Cal Rosete, Annie Vogel Ciernia","doi":"10.1080/17501911.2024.2419357","DOIUrl":"10.1080/17501911.2024.2419357","url":null,"abstract":"<p><p>Histone deacetylase 3 (HDAC3) is a critical regulator of gene expression, influencing a variety of cellular processes in the central nervous system. As such, dysfunction of this enzyme may serve as a key driver in the pathophysiology of various neuropsychiatric disorders and neurodegenerative diseases. HDAC3 plays a crucial role in regulating neuroinflammation, and is now widely recognized as a major contributor to neurological conditions, as well as in promoting neuroprotective recovery following brain injury, hemorrhage and stroke. Emerging evidence suggests that pharmacological inhibition of HDAC3 can mitigate behavioral and neuroimmune deficits in various brain diseases and disorders, offering a promising therapeutic strategy. Understanding HDAC3 in the healthy brain lays the necessary foundation to define and resolve its dysfunction in a disease state. This review explores the mechanisms of HDAC3 in various cell types and its involvement in disease pathology, emphasizing the potential of HDAC3 inhibition to address neuroimmune, gene expression and behavioral deficits in a range of neurodegenerative and neuropsychiatric conditions.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1373-1388"},"PeriodicalIF":3.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11728336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142603219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-10-28DOI: 10.1080/17501911.2024.2415278
Yeon-Su Lee, Yong Sun Lee
nc886 is a regulatory noncoding RNA that is transcribed by RNA polymerase III (Pol III), is variably expressed in different biological contexts, and plays roles in inflammation and cancer. Epigenetic mechanisms play an intriguing role in regulating nc886 expression. As a maternally imprinted gene and metastable epiallele, nc866 exhibits polymorphic imprinting, with a methylation status that is influenced by environmental and biological factors. Consequently, the promoter DNA methylation status and the different resulting RNA expression levels of nc886 are associated with physiological and pathological conditions. In this review, we summarize the literature and explore the significance in relation to diverse roles of nc886.
{"title":"The mystique of epigenetic regulation: the remarkable case of a human noncoding RNA, nc886.","authors":"Yeon-Su Lee, Yong Sun Lee","doi":"10.1080/17501911.2024.2415278","DOIUrl":"10.1080/17501911.2024.2415278","url":null,"abstract":"<p><p>nc886 is a regulatory noncoding RNA that is transcribed by RNA polymerase III (Pol III), is variably expressed in different biological contexts, and plays roles in inflammation and cancer. Epigenetic mechanisms play an intriguing role in regulating nc886 expression. As a maternally imprinted gene and metastable epiallele, nc866 exhibits polymorphic imprinting, with a methylation status that is influenced by environmental and biological factors. Consequently, the promoter DNA methylation status and the different resulting RNA expression levels of nc886 are associated with physiological and pathological conditions. In this review, we summarize the literature and explore the significance in relation to diverse roles of nc886.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1389-1405"},"PeriodicalIF":3.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11728332/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142497486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-11-12DOI: 10.1080/17501911.2024.2408217
Stephanie W Waldrop, Wei Perng, Iain R Konigsberg, Sarah J Borengasser
Our understanding of the origins of noncommunicable diseases has evolved over the years with greater consideration given to the lasting influence exposures and experiences during the preconceptional and prenatal periods can have. Research highlights the associations of parental exposures (e.g., diet, obesity, gestational diabetes, lipid profile, toxic exposures and microbiome) with the infant/fetal methylome and suggest associations with infant, child and/or adolescent chronic health outcomes. Thus, epigenetics and specifically cord blood DNA methylation may have utility as biomarkers for disease risk identification and stratification in pediatrics. However, for cord blood DNA methylation analyses to be leveraged as biomarkers of disease risk in pediatric clinical practice, the results must be replicable, validated and clinically meaningful. Challenges and opportunities to this prospect are herein discussed.
多年来,我们对非传染性疾病起源的认识不断发展,更多地考虑到了孕前和产前期间的接触和经历可能产生的持久影响。研究强调了父母暴露(如饮食、肥胖、妊娠糖尿病、血脂状况、有毒暴露和微生物组)与婴儿/胎儿甲基组的关联,并提出了与婴儿、儿童和/或青少年慢性健康结果的关联。因此,表观遗传学,特别是脐带血 DNA 甲基化可作为儿科疾病风险识别和分层的生物标志物。然而,要在儿科临床实践中将脐带血DNA甲基化分析用作疾病风险的生物标志物,其结果必须是可复制的、经过验证的和有临床意义的。本文讨论了这一前景所面临的挑战和机遇。
{"title":"The potential utility of cord blood DNA methylation in pediatric clinical practice.","authors":"Stephanie W Waldrop, Wei Perng, Iain R Konigsberg, Sarah J Borengasser","doi":"10.1080/17501911.2024.2408217","DOIUrl":"10.1080/17501911.2024.2408217","url":null,"abstract":"<p><p>Our understanding of the origins of noncommunicable diseases has evolved over the years with greater consideration given to the lasting influence exposures and experiences during the preconceptional and prenatal periods can have. Research highlights the associations of parental exposures (e.g., diet, obesity, gestational diabetes, lipid profile, toxic exposures and microbiome) with the infant/fetal methylome and suggest associations with infant, child and/or adolescent chronic health outcomes. Thus, epigenetics and specifically cord blood DNA methylation may have utility as biomarkers for disease risk identification and stratification in pediatrics. However, for cord blood DNA methylation analyses to be leveraged as biomarkers of disease risk in pediatric clinical practice, the results must be replicable, validated and clinically meaningful. Challenges and opportunities to this prospect are herein discussed.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1365-1372"},"PeriodicalIF":3.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: DNA methylation is associated with gastric cancer and Helicobacter pylori (H. pylori) infection, while increasing evidence indicated involvement of other microbes reside in gastric mucosa during gastric tumorigenesis. We investigated bacterial communities in the gastric mucosa accompanied with H. pylori related methylation anomaly.Materials & methods: Gastric mucosa samples from antrum were obtained from 182 cancer-free patients. Bacterial communities were evaluated using 16S rRNA sequencing. The result was correlated with H. pylori related promoter CpG island (CGI) methylation of five genes (IGF2, SLC16A12, SOX11, P2RX7 and MYOD1), LINE1 hypomethylation and telomere length.Results & conclusion: We showed correlation between lower bacterial alpha diversity and higher CGI methylation. Multivariate analysis demonstrated older age (t = 3.46, p = 0.0007), H. pylori infection (t = 9.99, p < 0.0001) and lower bacterial alfa diversity (Shannon index: t = -2.34, p = 0.02) were significantly associated with CGI hypermethylation. In genus or family levels, increased abundance of Helicobacter was associated with hyper CGI methylation with strongest correlation, while decreased abundance of four bacteria (Intrasporangiaceae family, Macellibacteroides, Peptostreptococcus and Dietziaceae family) was also associated with hyper CGI methylation. Our findings suggest the potential correlation between CGI methylation induction and lower bacterial alpha diversity in the gastric mucosa accompanied by H. pylori infection.
{"title":"Gastric microbiome composition accompanied with the <i>Helicobacter pylori</i> related DNA methylation anomaly.","authors":"Takuya Shijimaya, Tomomitsu Tahara, Tsubasa Shimogama, Jumpei Yamazaki, Sanshiro Kobayashi, Naohiro Nakamura, Yu Takahashi, Takashi Tomiyama, Toshiro Fukui, Makoto Naganuma","doi":"10.1080/17501911.2024.2418803","DOIUrl":"10.1080/17501911.2024.2418803","url":null,"abstract":"<p><p><b>Aim:</b> DNA methylation is associated with gastric cancer and <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection, while increasing evidence indicated involvement of other microbes reside in gastric mucosa during gastric tumorigenesis. We investigated bacterial communities in the gastric mucosa accompanied with <i>H. pylori</i> related methylation anomaly.<b>Materials & methods:</b> Gastric mucosa samples from antrum were obtained from 182 cancer-free patients. Bacterial communities were evaluated using 16S rRNA sequencing. The result was correlated with <i>H. pylori</i> related promoter CpG island (CGI) methylation of five genes (<i>IGF2, SLC16A12, SOX11, P2RX7 and MYOD1</i>), LINE1 hypomethylation and telomere length.<b>Results & conclusion:</b> We showed correlation between lower bacterial alpha diversity and higher CGI methylation. Multivariate analysis demonstrated older age (t = 3.46, <i>p</i> = 0.0007), <i>H. pylori</i> infection (t = 9.99, <i>p</i> < 0.0001) and lower bacterial alfa diversity (Shannon index: t = -2.34, <i>p</i> = 0.02) were significantly associated with CGI hypermethylation. In genus or family levels, increased abundance of <i>Helicobacter</i> was associated with hyper CGI methylation with strongest correlation, while decreased abundance of four bacteria (<i>Intrasporangiaceae family, Macellibacteroides</i>, <i>Peptostreptococcus</i> and <i>Dietziaceae family</i>) was also associated with hyper CGI methylation. Our findings suggest the potential correlation between CGI methylation induction and lower bacterial alpha diversity in the gastric mucosa accompanied by <i>H. pylori</i> infection.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1329-1336"},"PeriodicalIF":3.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11728328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}